HCPCS Level II · Drugs administered other than oral method
J0517Injection, benralizumab, 1 mg
✓ Active
Source: CMS HCPCS quarterly update, October 2026. Page updated September 29, 2026.
About J0517
J0517 is an HCPCS Level II code in the J series (drugs administered other than oral method), describing injection, benralizumab, 1 mg.
It was added to HCPCS effective 01/01/2019.
Its Medicare coverage code is "C", meaning coverage is left to the Medicare contractor's judgment.
Details
- Short description
- Inj., benralizumab, 1 mg
- Date added
- 01/01/2019
- Action effective
- 01/01/2019
- BETOS
- O1E
Related J05xx codes
- J0500Injection, dicyclomine hcl, up to 20 mg
- J0515Injection, benztropine mesylate, per 1 mg
- J0520Injection, bethanechol chloride, myotonachol or urecholine, up to 5 mg
- J0525Injection, cefotetan disodium, 10 mg
- J0528Injection, fosfomycin disodium, 20 mg
- J0558Injection, penicillin g benzathine and penicillin g procaine, 100,000 units
- J0561Injection, penicillin g benzathine, 100,000 units
- J0565Injection, bezlotoxumab, 10 mg
- J0567Injection, cerliponase alfa, 1 mg
- J0570Buprenorphine implant, 74.2 mg
- J0571Buprenorphine, oral, 1 mg
- J0572Buprenorphine/naloxone, oral, less than or equal to 3 mg buprenorphine
Common questions about J0517
Is HCPCS J0517 still valid?
- Yes. J0517 is active in the CMS October 2026 HCPCS file.
Does Medicare cover J0517?
- Its coverage code is "C": coverage is left to the Medicare contractor's judgment. Check the local coverage determination for your region.